×
Customize
?
Start
Cancer Types
Quick Links
Award Programs
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Prostate Cancer
Feature Video
Receiving a diagnosis of prostate cancer can be frightening and confusing. Understanding the details of your specific cancer and how they relate to your prognosis and treatment planning is an important first step toward shared decision-making between you and your physicians. In these CURE Connections programs you will learn the meaning of the PSA test, prostate cancer staging and grading, and how these factors are used to determine which treatment approach is right for you. Management of prostate cancer related symptoms, available treatments, and how to deal with side effects are also discussed. In addition, you will hear from patients and caregivers about their personal experiences with prostate cancer.
Tamera Anderson-Hanna
Being a caregiver and survivor takes adjusting to the diagnosis of the "C" word. Until there is a cure for cancer, may we all do our best to put one breath and foot in front of another.
Katie Kosko
A person’s pre-existing mental state may negatively influence their health, but professional support can help maintain the best mindset, say researchers.
Prostate Cancer Foundation
Prostate Cancer Foundation
Prostate Cancer Foundation
Alexandra Guadagno
From FDA news to today’s top performers and entertainers, here’s what’s making headlines in the cancer space this week.
Gina Columbus
In topline findings from the phase 3 TITAN trial (NCT02489318) announced today by Janssen, Erleada (apalutamide) in combination with androgen deprivation therapy (ADT) significantly improved radiographic progression-free survival (rPFS) and overall survival (OS) versus placebo in patients with metastatic castration-sensitive prostate cancer.
Robert Heywood
A prostate cancer survivor offers his thoughts on what you should (and shouldn't) say to someone who was recently diagnosed.
ARLENE WEINTRAUB
Men with advanced prostate cancer may benefit from genomic testing as BRCA and other gene mutations play a bigger role in guiding treatment.